|
1
|
World Health Organization: Media Centre
(2017) Obesity and overweight: Key facts. http://www.who.int/mediacentre/fact-sheets/fs311/en/.
Accessed February 16, 2018.
|
|
2
|
Kopelman PG: Obesity as a medical problem.
Nature. 404:635–643. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jo J, Gavrilova O, Pack S, Jou W, Mullen
S, Sumner AE, Cushman SW and Periwal V: Hypertrophy and/or
hyperplasia: Dynamics of adipose tissue growth. PLoS Comput Biol.
5:e10003242009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Langin D, Dicker A, Tavernier G, Hoffstedt
J, Mairal A, Rydén M, Arner E, Sicard A, Jenkins CM, Viguerie N, et
al: Adipocyte lipases and defect of lipolysis in human obesity.
Diabetes. 54:3190–3197. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Muoio DM, Seefeld K, Witters LA and
Coleman RA: AMP-activated kinase reciprocally regulates
triacylglycerol synthesis and fatty acid oxidation in liver and
muscle: Evidence that sn-glycerol-3-phosphate acyltransferase is a
novel target. Biochem J. 338:783–791. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cowherd RM, Lyle RE and McGehee RE Jr:
Molecular regulation of adipocyte differentiation. Semin Cell Dev
Biol. 10:3–10. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lane MD, Lin FT, MacDougald OA and
Vasseur-Cognet M: Control of adipocyte differentiation by
CCAAT/enhancer binding protein alpha (C/EBP alpha). Int J Obes
Relat Metab Disord. 20(Suppl 3): S91–S96. 1996.PubMed/NCBI
|
|
8
|
Farmer SR: Regulation of PPARgamma
activity during adipo-genesis. Int J Obes (Lond). 29(Suppl 1):
S13–S16. 2005. View Article : Google Scholar
|
|
9
|
Shi Y and Burn P: Lipid metabolic enzymes:
Emerging drug targets for the treatment of obesity. Nat Rev Drug
Discov. 3:695–710. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zechner R, Kienesberger PC, Haemmerle G,
Zimmermann R and Lass A: Adipose triglyceride lipase and the
lipolytic catabolism of cellular fat stores. J Lipid Res. 50:3–21.
2009. View Article : Google Scholar
|
|
11
|
Gao Y, Zhou Y, Xu A and Wu D: Effects of
an AMP-activated protein kinase inhibitor, compound C, on
adipogenic differentiation of 3T3-L1 cells. Biol Pharm Bull.
31:1716–1722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee HM, Yang G, Ahn TG, Kim MD, Nugroho A,
Park HJ, Lee KT, Park W and An HJ: Antiadipogenic effects of aster
glehni extract: In vivo and in vitro effects. Evid Based Complement
Alternat Med. 2013:8596242013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gupta A, Kumar A, Kumar D, Nandan S,
Shankar K, Varshney S, Rajan S, Srivastava A, Gupta S, Kanojiya S,
et al: Ethyl acetate fraction of eclipta alba: A potential
phytopharmaceutical targeting adipocyte differentiation. Biomed
Pharmacother. 96:572–583. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng Z, Hai-ning Y, Xiao-man C, Zun-chen
W, Sheng-rong S and Das UN: Effect of yellow capsicum extract on
proliferation and differentiation of 3T3-L1 preadipocytes.
Nutrition. 30:319–325. 2014. View Article : Google Scholar
|
|
15
|
Jin W, Thuong PT, Su ND, Min BS, Son KH,
Chang HW, Kim HP, Kang SS, Sok DE and Bae K: Antioxidant activity
of cleomiscosins A and C isolated from Acer okamotoanum. Arch Pharm
Res. 30:275–281. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee J, Lee DG, Rodriguez JP, Park JY, Cho
EJ, Jacinto SD and Lee S: Determination of flavonoids in Acer
okamotoanum and their aldose reductase inhibitory activities.
Hortic Environ Biotechnol. 59:131–137. 2018. View Article : Google Scholar
|
|
17
|
Yoo YM, Jung EM, Kang HY, Choi IG, Choi KC
and Jeung EB: The sap of Acer okamotoanum decreases serum alcohol
levels after acute ethanol ingestion in rats. Int J Mol Med.
28:489–495. 2011.PubMed/NCBI
|
|
18
|
An BS, Kang JH, Yang H, Yang MP and Jeung
EB: Effects of Acer okamotoanum sap on the function of
polymorphonuclear neutrophilic leukocytes in vitro and in vivo. Mol
Med Rep. 7:654–658. 2013. View Article : Google Scholar
|
|
19
|
Yang H, Hwang I, Koo TH, Ahn HJ, Kim S,
Park MJ, Choi WS, Kang HY, Choi IG, Choi KC and Jeung EB:
Beneficial effects of Acer okamotoanum sap on L-NAME-induced
hypertension-like symptoms in a rat model. Mol Med Rep. 5:427–431.
2012.
|
|
20
|
Choi SY, Kim JH, Lee J, Lee S and Cho EJ:
Protective effect of Acer okamotoanum from oxidative stress in C6
glial cells. J Appl Biol Chem. 60:141–147. 2017. View Article : Google Scholar
|
|
21
|
Choi SY, Lee J, Lee DG, Lee S and Cho EJ:
Acer okamotoanum improves cognition and memory function in
Aβ25-35-induced Alzheimer's mice model. Appl Biol Chem. 60:1–9.
2017. View Article : Google Scholar
|
|
22
|
Kim EJ, Kang MJ, Seo YB, Nam SW and Kim
GD: Acer okamotoanum nakai leaf extract inhibits adipogenesis via
suppressing expression of PPARγ and C/EBPα in 3T3-L1 cells. J
Microbiol Biotechnol. 28:1645–1653. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: Application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ramírez-Zacarías JL, Castro-Muñozledo F
and Kuri-Harcuch W: Quantitation of adipose conversion and
triglycerides by staining intracytoplasmic lipids with oil red O.
Histochemistry. 97:493–497. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zebisch K, Voigt V, Wabitsch M and
Brandsch M: Protocol for effective differentiation of 3T3-L1 cells
to adipocytes. Anal Biochem. 425:88–90. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang QQ, Otto TC and Lane MD:
CCAAT/enhancer-binding protein beta is required for mitotic clonal
expansion during adipogenesis. Proc Natl Acad Sci USA. 100:850–855.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moseti D, Regassa A and Kim WK: Molecular
regulation of adipogenesis and potential anti-adipogenic bioactive
molecules. Int J Mol Sci. 17:E1242016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ntambi JM and Young-Cheul K: Adipocyte
differentiation and gene expression. J Nutr. 130:3122S–3126S. 2000.
View Article : Google Scholar
|
|
29
|
Abdali D, Samson SE and Grover AK: How
effective are antioxidant supplements in obesity and diabetes? Med
Princ Pract. 24:201–215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schmid B, Rippmann JF, Tadayyon M and
Hamilton BS: Inhibition of fatty acid synthase prevents
preadipocyte differentiation. Biochem Biophys Res Commun.
328:1073–1082. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gregoire FM, Smas CM and Sul HS:
Understanding adipocyte differentiation. Physiol Rev. 78:783–809.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ma X, Zhang H, Yuan L, Jing H, Thacker P
and Li D: CREBL2, interacting with CREB, induces adipogenesis in
3T3-L1 adipo-cytes. Biochem J. 439:27–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hernandez R, Teruel T and Lorenzo M:
Insulin and dexamethasone induce GLUT4 gene expression in foetal
brown adipocytes: Synergistic effect through CCAAT/enhancer-binding
protein alpha. Biochem J. 372:617–624. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shen WJ, Patel S, Miyoshi H, Greenberg AS
and Kraemer FB: Functional interaction of hormone sensitive lipase
and perilipin in lipolysis. J Lipid Res. 50:2306–2313. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sztalryd C and Kraemer FB: Regulation of
hormone-sensitive lipase in streptozotocin-induced diabetic rats.
Metabolism. 44:1391–1396. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zimmermann R, Strauss JG, Haemmerle G,
Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger
G, Eisenhaber F, Hermetter A and Zechner R: Fat mobilization in
adipose tissue is promoted by adipose triglyceride lipase. Science.
306:1383–1386. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang X, Zhang X, Heckmann BL, Lu X and Liu
J: Relative contribution of adipose triglyceride lipase and
hormone-sensitive lipase to tumor necrosis factor-α (TNF-α)-induced
lipolysis in adipocytes. J Biol Chem. 286:40477–40485. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lim CT, Kola B and Korbonits M: AMPK as a
mediator of hormonal signalling. J Mol Endocrinol. 44:87–97. 2010.
View Article : Google Scholar
|
|
39
|
Daval M, Foufelle F and Ferré P: Functions
of AMP-activated protein kinase in adipose tissue. J Physiol.
574:55–62. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gaidhu MP, Fediuc S, Anthony NM, So M,
Mirpourian M, Perry RL and Ceddia RB: Prolonged AICAR-induced
AMP-kinase activation promotes energy dissipation in white
adipocytes: Novel mechanisms integrating HSL and ATGL. J Lipid Res.
50:704–715. 2009. View Article : Google Scholar :
|
|
41
|
Chen S, Li Z, Li W, Shan Z and Zhu W:
Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via
activation of AMPK. Can J Physiol Pharmacol. 89:793–799.
2011.PubMed/NCBI
|
|
42
|
Kang SW, Kang SI, Shin HS, Yoon SA, Kim
JH, Ko HC and Kim SJ: Sasa quelpaertensis nakai extract and its
constituent p-coumaric acid inhibit adipogenesis in 3T3-L1 cells
through activation of the AMPK pathway. Food Chem Toxicol.
59:380–385. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kang K, Liu W, Albright KJ, Park Y and
Pariza MW: Trans-10, cis-12 CLA inhibits differentiation of 3T3-L1
adipocytes and decreases PPAR gamma expression. Biochem Biophys Res
Commun. 303:795–779. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Moon HS, Lee HG, Seo JH, Chung CS, Kim TG,
Kim IY, Lim KW, Seo SJ, Choi YJ and Cho CS: Downregulation of
PPARgamma2-induced adipogenesis by PEGylated conjugated linoleic
acid as the pro-drug: Attenuation of lipid accumulation and
reduction of apoptosis. Arch Biochem Biophys. 456:19–29. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jiang S, Chen H, Wang Z, Riethoven JJ, Xia
Y, Miner J and Fromm M: Activated AMPK and prostaglandins are
involved in the response to conjugated linoleic acid and are
sufficient to cause lipid reductions in adipocytes. J Nutr Biochem.
22:656–664. 2011. View Article : Google Scholar
|
|
46
|
Bi W, Gao Y, Shen J, He C, Liu H, Peng Y,
Zhang C and Xiao P: Traditional uses, phytochemistry, and
pharmacology of the genus Acer (maple): A review. J Ethnopharmacol.
189:31–60. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhao WH, Gao LF, Gao W, Yuan YS, Gao CC,
Cao LG, Hu ZZ, Guo JQ and Zhang YX: Weight-reducing effect of Acer
truncatum bunge may be related to the inhibition of fatty acid
synthase. Nat Prod Res. 25:422–431. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gao L, Cao L, Tian M and Chen Z: Study on
the weight-reducing effect of Acer truncatum leave extract in
alimentary obesity rat. Wei Sheng Yan Jiu. 41:609–611. 2012.In
Chinese.
|
|
49
|
Lee CW, Seo JY, Lee J, Choi JW, Cho S, Bae
JY, Sohng JK, Kim SO, Kim J and Park YI: 3-O-Glucosylation of
quercetin enhances inhibitory effects on the adipocyte
differentiation and lipogenesis. Biomed Pharmacother. 95:589–598.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nabavi SF, Russo GL, Daglia M and Nabavi
SM: Role of quer-cetin as an alternative for obesity treatment: You
are what you eat! Food Chem. 179:305–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen S, Jiang H, Wu X and Fang J:
Therapeutic effects of quer-cetin on inflammation, obesity, and
type 2 diabetes. Mediators Inflamm. 2016:93406372016. View Article : Google Scholar
|
|
52
|
Lee YJ, Choi HS, Seo MJ, Jeon HJ, Kim KJ
and Lee BY: Kaempferol suppresses lipid accumulation by inhibiting
early adipogenesis in 3T3-L1 cells and zebrafish. Food Funct.
6:2824–2833. 2015. View Article : Google Scholar : PubMed/NCBI
|
